Comprehensive geriatric assessment and its clinical impact in oncology.
about
Comprehensive geriatric assessment for older women with early breast cancer - a systematic review of literatureOlder breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up.The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approachChemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.Safety and tolerance of radical hysterectomy for cervical cancer in the elderlySystematic comprehensive geriatric assessment in elderly patients on chronic dialysis: a cross-sectional comparative and feasibility study.The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients.Four screening instruments for frailty in older patients with and without cancer: a diagnostic studyFebrile neutropenia in chemotherapy treated small-cell lung cancer patientsGeriatric assessment-identified deficits in older cancer patients with normal performance status.The prevalence and outcomes of frailty in older cancer patients: a systematic review.Palliative chemotherapy for gastroesophageal cancer in old and very old patients: A retrospective cohort study at the National Center for Tumor Diseases, HeidelbergThe value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer.The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people.Biological ageing and frailty markers in breast cancer patientsFrailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study.Differences in the therapeutic approach to colorectal cancer in young and elderly patientsThe value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancerPatterns of care and treatment outcomes in older patients with biliary tract cancerToxicity of initial chemotherapy in older patients with lung cancers.Assessment of health status in elderly patients with cancer.EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts' opinion for the treatment of non-small-cell lung cancer in an elderly population.Clinico-Pathological Caracteristics, Therapeutic Features and Post-operative Course of Colorectal Cancer in Elderly PatientsCancer in older people: a tale of two disciplines.Choices in surgery for older women with breast cancer.Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making.Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: a systematic review.Pharmacotherapy for treatment of lung cancer in the elderly.Secondary immunodeficiency in lymphoproliferative malignancies.Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer.The current status of prophylactic femoral intramedullary nailing for metastatic cancerWhich better predicts mortality among older men, a prostate cancer (PCa) diagnosis or vulnerability on the Vulnerable Elders Survey (VES-13)? A retrospective cohort study.Perception of primary care physicians on the impact of comprehensive geriatric assessment: what is the next step?Translation Requires Evidence: Does Cancer-Specific CGA Lead to Better Care and Outcomes?Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.Prevalence and risk factors of frailty among home care clients.Treatment of the postoperative recurrence of lung cancer in octogenarians.Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?Engineering the fitness of older patients for chemotherapy: an exploration of Comprehensive Geriatric Assessment in practice.
P2860
Q27002642-0AEAE21E-62AE-4FFB-B67D-0144A4265E95Q33627703-E0EE7A53-AACF-4735-B5E4-84163A9475B1Q33878770-BB4086A5-77A5-4048-8917-37EBA4CF6A47Q33899433-49A3476D-0B53-41F9-B5CE-A2ED94C0D99EQ34150745-093D861A-12FF-4F7E-8EC6-CB2A7186C100Q34285947-2A495025-42DD-4234-89FC-F22672E10A3CQ34968015-17A1D1B0-E9CF-4A15-A6C2-4306DC0197F7Q35103189-38AF2273-C316-4B9B-BDC7-A39ECC715BD8Q35297079-0BB314A8-3C6F-46C1-8BA6-72A028FCBF6DQ35345579-899EAD4C-F346-4F00-90FE-5F1AC0AEC4A3Q35430157-A67777CA-3527-43AA-B8A0-A834748BEECBQ35534052-5A57DA2B-8A55-4D17-8E6F-C313BCD48253Q35584387-F6F7ECF7-BBA1-4BD3-9178-E32AFCF25F92Q35677917-630CECB1-F228-4A5D-8F8C-13422B3FF8D3Q35744970-91E515F0-B16D-4E09-B7F6-3FE675C4FA4AQ35937115-166B9CCD-56D9-46BC-8CB5-F33D7E3407A6Q36349591-0C344373-CA87-4062-AC31-ABD61A9D8FADQ36405665-15342650-D7BD-4DB4-A6A5-5BCC7237E19BQ36689150-E8897BCA-1804-4089-A50D-4F895C80D5B3Q36697134-7AD6F03C-D412-4D3E-BCE8-BBE5EA6BF17DQ37392175-303113F3-3F4A-4210-9440-E209F36C8FB9Q37589341-1E957619-5E44-4B93-8276-63918AE03E48Q37612039-178A89FF-3CC7-410F-9BAA-4482A9AB85BAQ37632544-84734153-7767-433C-9C40-CEBBBC227A58Q37677722-5C7A1F28-F3B9-4FA0-89E6-57359C4F82DAQ37884483-12C15CE2-B1FB-4FB5-A0F3-5AC15E576193Q38191160-C4D7779B-220B-4537-8EE5-F74281ADCEA1Q38386745-7E5088A6-C143-4ED8-BFB0-0863CE7D03E7Q38893343-667FF549-5ECD-46A6-8C4F-B824F4396308Q38910410-944D2482-3690-486F-B7FC-1CF989860E1AQ39095826-AAAFA6A0-9638-4D67-A018-BC0B005B429CQ40394555-46F328D9-5853-45F3-870D-E0178097B4A7Q42388832-50072FF9-0112-4A27-9F42-CF524C23D360Q42489074-0F1393FB-4525-4834-8484-39C5AB2AB23AQ43529176-BE2FF15E-F85A-4EE2-B1B2-38A80C4FE4C9Q43834616-D86FEF09-85EB-45F4-B103-AEB5979E478DQ45716949-6E615745-9FEA-4886-AB61-FCE8E959F829Q46114940-ECC16012-1E40-4071-BDDA-171923822642Q46340643-EB02A9A2-F7DF-483B-8920-D37318513044Q46901931-A5FE7A2E-F576-4F45-8FCC-C24FB8C13EA9
P2860
Comprehensive geriatric assessment and its clinical impact in oncology.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Comprehensive geriatric assessment and its clinical impact in oncology.
@ast
Comprehensive geriatric assessment and its clinical impact in oncology.
@en
type
label
Comprehensive geriatric assessment and its clinical impact in oncology.
@ast
Comprehensive geriatric assessment and its clinical impact in oncology.
@en
prefLabel
Comprehensive geriatric assessment and its clinical impact in oncology.
@ast
Comprehensive geriatric assessment and its clinical impact in oncology.
@en
P2093
P1476
Comprehensive geriatric assessment and its clinical impact in oncology.
@en
P2093
A N Machteld Wymenga
Huub A A M Maas
Marcel G M Olde Rikkert
Maryska L G Janssen-Heijnen
P304
P356
10.1016/J.EJCA.2007.08.002
P577
2007-09-12T00:00:00Z